溶瘤病毒领域是一个正在成长的治疗癌症的领域。
The field of oncolytic viruses is a growing area in identifying new therapies for treating cancer.
相比之下，溶瘤病毒就可以复制传播，理论上可以到达更多的肿瘤细胞。
In comparison, oncolytic viruses can replicate and spread and theoretically can efficiently reach more tumor cells.
文章简要综述了溶瘤病毒肿瘤治疗的靶向性、杀伤性、安全性和疗效监测。
In this review, tumor targeting, killing efficiency, safety and the evaluation of oncolytic viruses therapy are discussed.
本研究探索溶瘤腺病毒h 101局部注射结合局部加热治疗诱发远端抗瘤效应的可行性。
The study was to observe the induction of abscopal effect by the combination of H101 oncolytic virotherapy with local heating.
结论：改进的方法是一种高效、简便、快捷地包装并纯化重组溶瘤腺病毒的方法，采用该方法包装的重组溶瘤腺病毒能满足实验的需要。
Conclusion: It is a simple, rapid and high efficient method for the packaging and cloning purification of recombination adenovirus, which meet the demands of subsequent experiments.
该新型溶瘤腺病毒突变体在基因治疗中具有良好的临床应用前景，可用于多种人体肿瘤的治疗。
This new oncolytic adenovirus mutant has good clinical prospect in gene curing so to used in curing many kinds of human tumors.
结论：不同的肿瘤细胞对VSV病毒溶瘤的敏感性不同；
Conclusion: Different tumor cell lines showed different VSV oncolytic sensitivities;
结论：不同的肿瘤细胞对VSV病毒溶瘤的敏感性不同；
Conclusion: Different tumor cell lines showed different VSV oncolytic sensitivities;
应用推荐